Your Search Returned 333 tagged news reports
An experimental gene therapy injected into the brains of patients with Parkinson's disease improved tremor, stiffness, and other movement symptoms and was safe with few side effects over six months of follow-up, a study shows.
Yet now that the French drug giant and Cambridge, MA-based biotech company have agreed to terms of a $20.1 billion buyout , local players in the market for rare disease drugs are contemplating what Sanofi's huge move into their field means for them.
Boston on Wednesday, a gene therapy expert at the University of Pennsylvania, Carl June, presented data from nine HIV-positive patients who received the novel treatment in Philadelphia, New York and California beginning in July 2009...In addition to
Scientists utilized genetic engineering in six patients to arise blood cells that are unaffected by to HIV, the virus that set off the disease in a bold new line of attack eventually meant at attempting to heal AIDS.
Skooter report 03/01/11 Scientists have a new bold approach to ultimately cure AIDS. They used genetic engineering in six patients to develop blood cells that are resistant to HIV, the virus that causes the disease. This
HIV, the virus that causes the disease. It's far too early to know if this scientific first will prove to be a cure, or even a new treatment...Researchers are seeking a more practical way to achieve similar immunity using
T holds the commercialization rights to the AIP gene therapy (AMT-021). Under this grant, AMT expects to obtain EUR1.1m, which will cover almost 75% of AMT's overall development cost of the product to complete Phase I/II study in humans. With the
Medical School The following is an introduction to Jewish genetic diseases, which I will explore in greater detail with you the reader over the next two years. I will attempt to provide answers to some of the many questions asked by potential
Finding a gene that triggers the spread of eye melanoma was a discovery whose time had come, said researcher Dr. J. William Harbour, professor of ophthalmology and visual sciences at Washington University School of Medicine. The discovery
Genethon form research collaboration bluebird bio (formerly Genetix Pharmaceuticals) and Genethon have formed a research collaboration focused on process development and scale up efforts for the manufacturing of lentiviral vectors. The agreement is